Is Sweetgreen Stock Worth Holding For the Next Five Years?
Sweetgreen (NYSE:SG) is an up-and-coming quick service restaurant chain focused…
Sell
38
ARZTY Quote, Financials, Valuation and Earnings
Last price:
$1.00
Seasonality move
:
1.02%
Day range:
$0.91 - $1.05
52-week range:
$0.80 - $1.20
Dividend yield:
0%
P/E ratio:
17.09x
P/S ratio:
0.78x
P/B ratio:
3.85x
Volume:
5.3K
Avg. volume:
1.4K
1-year change:
1.07%
Market cap:
$1.8B
Revenue:
$2.4B
EPS (TTM):
$0.05
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ARZTY
Aryzta AG
|
-- | -- | -- | -- | -- |
|
BRRLY
Barry Callebaut AG
|
-- | -- | -- | -- | -- |
|
CCHGY
Coca-Cola HBC AG
|
$2.5B | -- | -- | -- | -- |
|
CHLSY
Chocoladefabriken Lindt & Spruengli AG
|
-- | -- | -- | -- | -- |
|
EMLZF
Emmi AG
|
-- | -- | -- | -- | -- |
|
NSRGY
Nestle SA
|
$25.6B | -- | -- | -- | $101.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ARZTY
Aryzta AG
|
$0.91 | -- | $1.8B | 17.09x | $0.00 | 0% | 0.78x |
|
BRRLY
Barry Callebaut AG
|
$11.90 | -- | $6.5B | 30.60x | $0.32 | 2.67% | 0.55x |
|
CCHGY
Coca-Cola HBC AG
|
$45.10 | -- | $16.3B | 18.72x | $1.00 | 2.21% | 1.43x |
|
CHLSY
Chocoladefabriken Lindt & Spruengli AG
|
$13.76 | -- | $31.7B | 42.08x | $0.15 | 1.11% | 5.18x |
|
EMLZF
Emmi AG
|
$897.63 | -- | $4.8B | 19.41x | $16.96 | 1.89% | 0.98x |
|
NSRGY
Nestle SA
|
$100.61 | $101.00 | $258.8B | 21.41x | $3.28 | 3.26% | 2.54x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ARZTY
Aryzta AG
|
59.49% | -0.185 | 40.72% | 0.39x |
|
BRRLY
Barry Callebaut AG
|
61.23% | -1.071 | 59.59% | 0.31x |
|
CCHGY
Coca-Cola HBC AG
|
53.76% | -0.251 | 31.28% | 0.91x |
|
CHLSY
Chocoladefabriken Lindt & Spruengli AG
|
19.79% | -1.006 | 5.04% | 1.13x |
|
EMLZF
Emmi AG
|
57.01% | 0.056 | 26.78% | 1.26x |
|
NSRGY
Nestle SA
|
63.89% | -0.271 | 33.33% | 0.48x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ARZTY
Aryzta AG
|
-- | -- | 10.86% | 19.4% | -- | -- |
|
BRRLY
Barry Callebaut AG
|
-- | -- | 3.24% | 6.54% | -- | -- |
|
CCHGY
Coca-Cola HBC AG
|
-- | -- | 12.01% | 25.91% | -- | -- |
|
CHLSY
Chocoladefabriken Lindt & Spruengli AG
|
-- | -- | 11.87% | 14.92% | -- | -- |
|
EMLZF
Emmi AG
|
-- | -- | 9.78% | 16.28% | -- | -- |
|
NSRGY
Nestle SA
|
-- | -- | 11.08% | 30.2% | -- | -- |
Aryzta AG vs. Competitors
-
Which has Higher Returns ARZTY or BRRLY?
Barry Callebaut AG has a net margin of -- compared to Aryzta AG's net margin of --. Aryzta AG's return on equity of 19.4% beat Barry Callebaut AG's return on equity of 6.54%.
Company Gross Margin Earnings Per Share Invested Capital ARZTYAryzta AG-- -- $1.2B BRRLYBarry Callebaut AG-- -- $8.6B -
What do Analysts Say About ARZTY or BRRLY?
Aryzta AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Barry Callebaut AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Aryzta AG has higher upside potential than Barry Callebaut AG, analysts believe Aryzta AG is more attractive than Barry Callebaut AG.
Company Buy Ratings Hold Ratings Sell Ratings ARZTYAryzta AG0 0 0 BRRLYBarry Callebaut AG0 0 0 -
Is ARZTY or BRRLY More Risky?
Aryzta AG has a beta of 0.641, which suggesting that the stock is 35.904% less volatile than S&P 500. In comparison Barry Callebaut AG has a beta of 0.270, suggesting its less volatile than the S&P 500 by 72.957%.
-
Which is a Better Dividend Stock ARZTY or BRRLY?
Aryzta AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Barry Callebaut AG offers a yield of 2.67% to investors and pays a quarterly dividend of $0.32 per share. Aryzta AG pays -- of its earnings as a dividend. Barry Callebaut AG pays out 83.74% of its earnings as a dividend. Barry Callebaut AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ARZTY or BRRLY?
Aryzta AG quarterly revenues are --, which are smaller than Barry Callebaut AG quarterly revenues of --. Aryzta AG's net income of -- is lower than Barry Callebaut AG's net income of --. Notably, Aryzta AG's price-to-earnings ratio is 17.09x while Barry Callebaut AG's PE ratio is 30.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aryzta AG is 0.78x versus 0.55x for Barry Callebaut AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARZTYAryzta AG0.78x 17.09x -- -- BRRLYBarry Callebaut AG0.55x 30.60x -- --
-
Which has Higher Returns ARZTY or CCHGY?
Coca-Cola HBC AG has a net margin of -- compared to Aryzta AG's net margin of --. Aryzta AG's return on equity of 19.4% beat Coca-Cola HBC AG's return on equity of 25.91%.
Company Gross Margin Earnings Per Share Invested Capital ARZTYAryzta AG-- -- $1.2B CCHGYCoca-Cola HBC AG-- -- $7.3B -
What do Analysts Say About ARZTY or CCHGY?
Aryzta AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Coca-Cola HBC AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Aryzta AG has higher upside potential than Coca-Cola HBC AG, analysts believe Aryzta AG is more attractive than Coca-Cola HBC AG.
Company Buy Ratings Hold Ratings Sell Ratings ARZTYAryzta AG0 0 0 CCHGYCoca-Cola HBC AG0 0 0 -
Is ARZTY or CCHGY More Risky?
Aryzta AG has a beta of 0.641, which suggesting that the stock is 35.904% less volatile than S&P 500. In comparison Coca-Cola HBC AG has a beta of 0.979, suggesting its less volatile than the S&P 500 by 2.117%.
-
Which is a Better Dividend Stock ARZTY or CCHGY?
Aryzta AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Coca-Cola HBC AG offers a yield of 2.21% to investors and pays a quarterly dividend of $1.00 per share. Aryzta AG pays -- of its earnings as a dividend. Coca-Cola HBC AG pays out 41.4% of its earnings as a dividend. Coca-Cola HBC AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ARZTY or CCHGY?
Aryzta AG quarterly revenues are --, which are smaller than Coca-Cola HBC AG quarterly revenues of --. Aryzta AG's net income of -- is lower than Coca-Cola HBC AG's net income of --. Notably, Aryzta AG's price-to-earnings ratio is 17.09x while Coca-Cola HBC AG's PE ratio is 18.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aryzta AG is 0.78x versus 1.43x for Coca-Cola HBC AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARZTYAryzta AG0.78x 17.09x -- -- CCHGYCoca-Cola HBC AG1.43x 18.72x -- --
-
Which has Higher Returns ARZTY or CHLSY?
Chocoladefabriken Lindt & Spruengli AG has a net margin of -- compared to Aryzta AG's net margin of --. Aryzta AG's return on equity of 19.4% beat Chocoladefabriken Lindt & Spruengli AG's return on equity of 14.92%.
Company Gross Margin Earnings Per Share Invested Capital ARZTYAryzta AG-- -- $1.2B CHLSYChocoladefabriken Lindt & Spruengli AG-- -- $6.7B -
What do Analysts Say About ARZTY or CHLSY?
Aryzta AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Chocoladefabriken Lindt & Spruengli AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Aryzta AG has higher upside potential than Chocoladefabriken Lindt & Spruengli AG, analysts believe Aryzta AG is more attractive than Chocoladefabriken Lindt & Spruengli AG.
Company Buy Ratings Hold Ratings Sell Ratings ARZTYAryzta AG0 0 0 CHLSYChocoladefabriken Lindt & Spruengli AG0 0 0 -
Is ARZTY or CHLSY More Risky?
Aryzta AG has a beta of 0.641, which suggesting that the stock is 35.904% less volatile than S&P 500. In comparison Chocoladefabriken Lindt & Spruengli AG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ARZTY or CHLSY?
Aryzta AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Chocoladefabriken Lindt & Spruengli AG offers a yield of 1.11% to investors and pays a quarterly dividend of $0.15 per share. Aryzta AG pays -- of its earnings as a dividend. Chocoladefabriken Lindt & Spruengli AG pays out 47.85% of its earnings as a dividend. Chocoladefabriken Lindt & Spruengli AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ARZTY or CHLSY?
Aryzta AG quarterly revenues are --, which are smaller than Chocoladefabriken Lindt & Spruengli AG quarterly revenues of --. Aryzta AG's net income of -- is lower than Chocoladefabriken Lindt & Spruengli AG's net income of --. Notably, Aryzta AG's price-to-earnings ratio is 17.09x while Chocoladefabriken Lindt & Spruengli AG's PE ratio is 42.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aryzta AG is 0.78x versus 5.18x for Chocoladefabriken Lindt & Spruengli AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARZTYAryzta AG0.78x 17.09x -- -- CHLSYChocoladefabriken Lindt & Spruengli AG5.18x 42.08x -- --
-
Which has Higher Returns ARZTY or EMLZF?
Emmi AG has a net margin of -- compared to Aryzta AG's net margin of --. Aryzta AG's return on equity of 19.4% beat Emmi AG's return on equity of 16.28%.
Company Gross Margin Earnings Per Share Invested Capital ARZTYAryzta AG-- -- $1.2B EMLZFEmmi AG-- -- $2.7B -
What do Analysts Say About ARZTY or EMLZF?
Aryzta AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Emmi AG has an analysts' consensus of -- which suggests that it could fall by --. Given that Aryzta AG has higher upside potential than Emmi AG, analysts believe Aryzta AG is more attractive than Emmi AG.
Company Buy Ratings Hold Ratings Sell Ratings ARZTYAryzta AG0 0 0 EMLZFEmmi AG0 0 0 -
Is ARZTY or EMLZF More Risky?
Aryzta AG has a beta of 0.641, which suggesting that the stock is 35.904% less volatile than S&P 500. In comparison Emmi AG has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ARZTY or EMLZF?
Aryzta AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Emmi AG offers a yield of 1.89% to investors and pays a quarterly dividend of $16.96 per share. Aryzta AG pays -- of its earnings as a dividend. Emmi AG pays out 37.64% of its earnings as a dividend. Emmi AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ARZTY or EMLZF?
Aryzta AG quarterly revenues are --, which are smaller than Emmi AG quarterly revenues of --. Aryzta AG's net income of -- is lower than Emmi AG's net income of --. Notably, Aryzta AG's price-to-earnings ratio is 17.09x while Emmi AG's PE ratio is 19.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aryzta AG is 0.78x versus 0.98x for Emmi AG. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARZTYAryzta AG0.78x 17.09x -- -- EMLZFEmmi AG0.98x 19.41x -- --
-
Which has Higher Returns ARZTY or NSRGY?
Nestle SA has a net margin of -- compared to Aryzta AG's net margin of --. Aryzta AG's return on equity of 19.4% beat Nestle SA's return on equity of 30.2%.
Company Gross Margin Earnings Per Share Invested Capital ARZTYAryzta AG-- -- $1.2B NSRGYNestle SA-- -- $111B -
What do Analysts Say About ARZTY or NSRGY?
Aryzta AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Nestle SA has an analysts' consensus of $101.00 which suggests that it could grow by 0.39%. Given that Nestle SA has higher upside potential than Aryzta AG, analysts believe Nestle SA is more attractive than Aryzta AG.
Company Buy Ratings Hold Ratings Sell Ratings ARZTYAryzta AG0 0 0 NSRGYNestle SA1 2 1 -
Is ARZTY or NSRGY More Risky?
Aryzta AG has a beta of 0.641, which suggesting that the stock is 35.904% less volatile than S&P 500. In comparison Nestle SA has a beta of 0.542, suggesting its less volatile than the S&P 500 by 45.837%.
-
Which is a Better Dividend Stock ARZTY or NSRGY?
Aryzta AG has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nestle SA offers a yield of 3.26% to investors and pays a quarterly dividend of $3.28 per share. Aryzta AG pays -- of its earnings as a dividend. Nestle SA pays out 71.81% of its earnings as a dividend. Nestle SA's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ARZTY or NSRGY?
Aryzta AG quarterly revenues are --, which are smaller than Nestle SA quarterly revenues of --. Aryzta AG's net income of -- is lower than Nestle SA's net income of --. Notably, Aryzta AG's price-to-earnings ratio is 17.09x while Nestle SA's PE ratio is 21.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aryzta AG is 0.78x versus 2.54x for Nestle SA. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ARZTYAryzta AG0.78x 17.09x -- -- NSRGYNestle SA2.54x 21.41x -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Do I Need to Know About Alcoa Stock?
Alcoa (AA) is a global leader in aluminum production. Based…
Is ROOT Stock the Next Big Thing?
Root Holdings (NASDAQ:ROOT) is the parent company of Root Insurance,…
Stock Ideas
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
31
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 32x
Alerts
Sell
45
RGC alert for Apr 7
Regencell Bioscience Holdings [RGC] is down 14.19% over the past day.
Sell
25
GDXU alert for Apr 7
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 2.56% over the past day.
Buy
76
SOXS alert for Apr 7
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 0.86% over the past day.
